96678 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
Antibody-Drug Conjugates Including Hemiasterlin Derivative
#2Antibody-drug conjugates including hemiasterlin derivative
#3THIENOPYRROLE COMPOUNDS AND USES THEREOF
#4Ether compounds for treatment of medical disorders
#5Thienopyrrole compounds and uses thereof
#6IMPROVED RAMIPRIL SYNTHESIS
#7Pharmaceutical intermediate for synthesizing ACE inhibitors and the use thereof
#8Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
#9Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
#10Process for the production of lisinopril
#11Crystalline forms
#12Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
#13Ace-inhibitors having antioxidant and no-donor activity
#14Method for synthesizing derivatives of (2S,3AS,7AS)-1-[(S)-alanyl]-octahydro,-1H-indole-2-carboxylic acid and the use thereof for perindopril synthesis
#15Method for synthesising perindopril and the pharmaceutically acceptable salt thereof
#16Method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
#17Nitroderivatives of cardiovascular agents
#18Proline ester and preparation containing the same for percutaneous administration
#19New peptide derivatives
#20Crystalline forms
#21Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
#22New alpha crystalline form of perindopril tert-butylamine salt
#23Crystalline forms of EtO2C-Ch2-(R)Cgi-Aze-Pab-OH
#24Concentrating aqueous fractions of lisinopril by reverse osmosis
#25ACE inhibitor derivatives